Preferred Label : Lipodystrophy, congenital generalized, type 2;
Symbol : CGL2;
CISMeF acronym : CGL2;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Berardinelli-seip congenital lipodystrophy, type 2; Lipodystrophy, berardinelli-seip congenital, type 2; Seip syndrome; Lipoatrophic diabetes, congenital; Berardinelli syndrome; Lipodystrophy, total, and acromegaloid gigantism; Brunzell syndrome, bscl2-related;
Description : Congenital generalized lipodystrophy (CGL), also known as Berardinelli-Seip syndrome,
is an autosomal recessive disorder characterized by marked paucity of adipose tissue,
extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset
of diabetes (Garg, 2004). For a general description and a discussion of genetic heterogeneity
of congenital generalized lipodystrophy, see CGL1 (608594).;
Inheritance : Autosomal recessive;
Molecular basis : Caused by mutations in the seipin gene (BSCL2, 606158.0001).;
Laboratory abnormalities : Hyperinsulinemia; Hypertriglyceridemia; Decreased serum leptin; Elevated liver enzymes;
Prefixed ID : #269700;
Origin ID : 269700;
UMLS CUI : C1720863;
Automatic exact mappings (from CISMeF team)
Broader ORDO disease(s)
Currated CISMeF NLP mapping
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT